Cargando…
Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group
BACKGROUND: The present study aimed to compare serum total IgA levels between severe and mild COVID-19 patients’ groups and the control group. METHODS: In this cross-sectional study, 216 definite severe COVID-19 patients (as the inpatient group), 183 subjects with positive specific COVID-19 IgG with...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542492/ https://www.ncbi.nlm.nih.gov/pubmed/34694544 http://dx.doi.org/10.1007/s10875-021-01149-6 |
_version_ | 1784589442278752256 |
---|---|
author | Barzegar-Amini, Maral Mahmoudi, Mahmoud Dadgarmoghaddam, Maliheh Farzad, Faramarz Najafabadi, Ali Qaraee Jabbari-Azad, Farahzad |
author_facet | Barzegar-Amini, Maral Mahmoudi, Mahmoud Dadgarmoghaddam, Maliheh Farzad, Faramarz Najafabadi, Ali Qaraee Jabbari-Azad, Farahzad |
author_sort | Barzegar-Amini, Maral |
collection | PubMed |
description | BACKGROUND: The present study aimed to compare serum total IgA levels between severe and mild COVID-19 patients’ groups and the control group. METHODS: In this cross-sectional study, 216 definite severe COVID-19 patients (as the inpatient group), 183 subjects with positive specific COVID-19 IgG with mild or no symptoms as the (outpatient group), and 203 healthy subjects with negative specific serology, as the control group were investigated. The cases’ laboratory data were collected, and thereafter, statistical tests, including independent samples t test, ANOVA test, and post hoc test, were performed using SPSS software version 22. RESULT: The mean ± SD of IgA in all the included subjects was 2.23 ± 0.78 (g/L). According to the obtained results, there were statistically significant changes in IgA among the three study groups (P value < 0.05). This difference was significant between both outpatient and inpatient groups (P value < 0.05). The mean ± SD of serum IgG in all the subjects was calculated as 15.83 ± 5.73 (g/L). A strong statistically significant change was also seen in IgG among all three groups (P value < 0.001). Of note, there was a significant negative correlation between IgG and IgA total titers of the outpatient group (P value = 0.011*r = − 0.188). CONCLUSION: It was shown that the total serum IgA and IgG levels are significantly associated with the severity of COVID-19 infection. As well, we found that total serum IgA and IgG are associated with the severity of illness. Since a low level of IgA is asymptomatic and high frequent in Iran and other countries, we suggest the evaluation of serum IgA levels in high-risk people and strengthening immune system in subjects with a low level of IgA, in order to reduce the rate of death. In this regard, oral or nasal mucosal vaccines in combination with parenteral vaccination are recommended due to increasing immunity versus COVID-19 by further secretion of the IgA antibody and preventing virus transmission. |
format | Online Article Text |
id | pubmed-8542492 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-85424922021-10-25 Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group Barzegar-Amini, Maral Mahmoudi, Mahmoud Dadgarmoghaddam, Maliheh Farzad, Faramarz Najafabadi, Ali Qaraee Jabbari-Azad, Farahzad J Clin Immunol Original Article BACKGROUND: The present study aimed to compare serum total IgA levels between severe and mild COVID-19 patients’ groups and the control group. METHODS: In this cross-sectional study, 216 definite severe COVID-19 patients (as the inpatient group), 183 subjects with positive specific COVID-19 IgG with mild or no symptoms as the (outpatient group), and 203 healthy subjects with negative specific serology, as the control group were investigated. The cases’ laboratory data were collected, and thereafter, statistical tests, including independent samples t test, ANOVA test, and post hoc test, were performed using SPSS software version 22. RESULT: The mean ± SD of IgA in all the included subjects was 2.23 ± 0.78 (g/L). According to the obtained results, there were statistically significant changes in IgA among the three study groups (P value < 0.05). This difference was significant between both outpatient and inpatient groups (P value < 0.05). The mean ± SD of serum IgG in all the subjects was calculated as 15.83 ± 5.73 (g/L). A strong statistically significant change was also seen in IgG among all three groups (P value < 0.001). Of note, there was a significant negative correlation between IgG and IgA total titers of the outpatient group (P value = 0.011*r = − 0.188). CONCLUSION: It was shown that the total serum IgA and IgG levels are significantly associated with the severity of COVID-19 infection. As well, we found that total serum IgA and IgG are associated with the severity of illness. Since a low level of IgA is asymptomatic and high frequent in Iran and other countries, we suggest the evaluation of serum IgA levels in high-risk people and strengthening immune system in subjects with a low level of IgA, in order to reduce the rate of death. In this regard, oral or nasal mucosal vaccines in combination with parenteral vaccination are recommended due to increasing immunity versus COVID-19 by further secretion of the IgA antibody and preventing virus transmission. Springer US 2021-10-25 2022 /pmc/articles/PMC8542492/ /pubmed/34694544 http://dx.doi.org/10.1007/s10875-021-01149-6 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Barzegar-Amini, Maral Mahmoudi, Mahmoud Dadgarmoghaddam, Maliheh Farzad, Faramarz Najafabadi, Ali Qaraee Jabbari-Azad, Farahzad Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group |
title | Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group |
title_full | Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group |
title_fullStr | Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group |
title_full_unstemmed | Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group |
title_short | Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group |
title_sort | comparison of serum total iga levels in severe and mild covid-19 patients and control group |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542492/ https://www.ncbi.nlm.nih.gov/pubmed/34694544 http://dx.doi.org/10.1007/s10875-021-01149-6 |
work_keys_str_mv | AT barzegaraminimaral comparisonofserumtotaligalevelsinsevereandmildcovid19patientsandcontrolgroup AT mahmoudimahmoud comparisonofserumtotaligalevelsinsevereandmildcovid19patientsandcontrolgroup AT dadgarmoghaddammaliheh comparisonofserumtotaligalevelsinsevereandmildcovid19patientsandcontrolgroup AT farzadfaramarz comparisonofserumtotaligalevelsinsevereandmildcovid19patientsandcontrolgroup AT najafabadialiqaraee comparisonofserumtotaligalevelsinsevereandmildcovid19patientsandcontrolgroup AT jabbariazadfarahzad comparisonofserumtotaligalevelsinsevereandmildcovid19patientsandcontrolgroup |